Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Arthur

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Cancer Genetics and Cytogenetics|July 15, 1989
Cytogenetic studies of 21 patients with acute lymphoblastic leukemia in relapseL M Secker-Walker, G Alimena, C D Bloomfield, et al.
Blood|May 15, 1997
MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemiaJ M Hilden, F O Smith, J L Frestedt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B studyW Stock, C A Westbrook, B Peterson, et al.
Blood|June 15, 1996
Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer GroupW G Woods, N Kobrinsky, J D Buckley, et al.
Cancer Research|September 29, 1998
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtypeC D Bloomfield, D Lawrence, J C Byrd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer GroupF M Uckun, M G Sensel, H N Sather, et al.
Blood|September 9, 1999
Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer GroupN A Heerema, H N Sather, M G Sensel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B studyJ L Slack, D C Arthur, D Lawrence, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer GroupN A Heerema, H N Sather, M G Sensel, et al.
Leukemia|January 1, 1996
Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer GroupD R Barnard, D K Kalousek, S R Wiersma, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Cancer Genetics and Cytogenetics|July 15, 1989
Cytogenetic studies of 21 patients with acute lymphoblastic leukemia in relapseL M Secker-Walker, G Alimena, C D Bloomfield, et al.
Blood|May 15, 1997
MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemiaJ M Hilden, F O Smith, J L Frestedt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B studyW Stock, C A Westbrook, B Peterson, et al.
Blood|June 15, 1996
Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer GroupW G Woods, N Kobrinsky, J D Buckley, et al.
Cancer Research|September 29, 1998
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtypeC D Bloomfield, D Lawrence, J C Byrd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer GroupF M Uckun, M G Sensel, H N Sather, et al.
Blood|September 9, 1999
Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer GroupN A Heerema, H N Sather, M G Sensel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B studyJ L Slack, D C Arthur, D Lawrence, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer GroupN A Heerema, H N Sather, M G Sensel, et al.
Leukemia|January 1, 1996
Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer GroupD R Barnard, D K Kalousek, S R Wiersma, et al.
Pageof 11